NVO
Novo Nordisk A/S
38.30$
+1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures per share in DKK.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.08 | 14.71 | 14.62 | 15.24 | 15.99 | 19.21 | 17.56 | 17.28 | 16.86 | 17.79 | 21.76 | 17.69 | 74.27 | |
| 2.16 | 2.24 | 2.22 | 2.30 | 2.54 | 2.92 | 2.90 | 2.89 | 4.03 | 3.41 | 3.06 | 3.85 | 14.37 | |
| 10.92 | 12.47 | 12.40 | 12.94 | 13.45 | 16.29 | 14.66 | 14.39 | 12.83 | 14.39 | 18.71 | 13.84 | 59.89 | |
| 1.81 | 2.34 | 1.93 | 3.62 | 2.13 | 3.09 | 2.32 | 2.63 | 3.46 | 3.29 | 2.31 | 4.01 | 13.10 | |
| 0.28 | 0.33 | 0.26 | 0.26 | 0.31 | 0.35 | 0.27 | 0.30 | 0.42 | 0.35 | 0.26 | 0.30 | 1.33 | |
| 4.92 | 6.50 | 5.28 | 7.13 | 5.87 | 8.05 | 5.94 | 6.87 | 7.51 | 7.25 | 5.31 | 7.74 | 27.86 | |
| 6.00 | 5.98 | 7.12 | 5.81 | 7.58 | 8.24 | 8.72 | 7.52 | 5.33 | 7.14 | 13.40 | 6.10 | 32.03 | |
| 0.48 | 0.20 | 0.46 | 0.35 | 0.18 | 1.14 | 1.17 | 1.11 | 1.13 | 1.94 | 0.79 | 0.34 | 4.20 | |
| 6.25 | 6.17 | 7.14 | 5.67 | 7.71 | 7.97 | 8.33 | 7.60 | 5.74 | 7.69 | 13.98 | 6.06 | 33.53 | |
| 1.24 | 1.26 | 1.46 | 1.18 | 1.59 | 1.64 | 1.80 | 1.64 | 1.24 | 1.64 | 3.06 | 1.33 | 7.28 | |
| 5.01 | 4.91 | 5.68 | 4.49 | 6.12 | 6.33 | 6.53 | 5.96 | 4.50 | 6.05 | 10.91 | 4.73 | 26.25 | |
| 7.30 | 6.37 | 8.26 | 8.00 | 8.37 | 10.28 | 10.36 | 9.80 | 7.48 | 8.94 | 15.56 | 8.72 | 40.78 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.